{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:53:18Z","timestamp":1791283998941,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic viral infections caused by highly contagious human papillomaviruses (\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      s) from the alpha genus are a substantial risk factor for tumour diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      The goal of this study was to compare the\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      infection pattern with histology in a patient group of immunocompromised\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      <jats:sup>+<\/jats:sup>\n                      and non\u2010immunocompromised patients with anal intraepithelial neoplasia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      Tissue samples (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0210) from the anogenital area of 121 patients underwent retrospective histological and molecular examination for\n                      <jats:styled-content style=\"fixed-case\">HPV DNA<\/jats:styled-content>\n                      prevalence by chip analysis. The study was part of a cancer screening from the Dermatology Department of the\n                      <jats:styled-content style=\"fixed-case\">LMU<\/jats:styled-content>\n                      Munich, Germany. All data were collected and processed anonymously.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      6 or 11 are more abundant in tissue samples from histologically diagnosed condylomata acuminata (47.7%) compared to grade 1, 2, and 3 intraepithelial neoplasias (\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      1\u20103). Detection of high\u2010risk (hr) alpha\u2010\n                      <jats:styled-content style=\"fixed-case\">HPV DNA<\/jats:styled-content>\n                      was significantly higher in tissue samples from\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      3 (67.5%) compared to\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      1 and 2 (12.9%), and compared to condylomata acuminata (29.5%). No\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      types were detected in histologically unremarkable tissue samples. There was a significant association between the prevalence of\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      16 and the classifications\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      1 to\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      3 (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      (2)\u00a0=\u00a013.62,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001). We identified a significant correlation between the prevalence of high\u2010risk and low\u2010risk (lr)\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      types and\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      , especially mixed infections of different\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      types correlated with high\u2010grade\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      . Based on the present data, we suggest the risk of carcinoma in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      <jats:sup>+\/\u2212<\/jats:sup>\n                      patients (\n                      <jats:styled-content style=\"fixed-case\">RICH<\/jats:styled-content>\n                      ) score and test it in the 121 patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      hr alpha\u2010\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      s, mainly\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      16, are associated with increased oncogenic potential of premalignant lesions (\n                      <jats:styled-content style=\"fixed-case\">IN<\/jats:styled-content>\n                      1\u20103), especially in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      <jats:sup>+<\/jats:sup>\n                      patients. Based on the combination of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\n                      \u2010testing and histological analysis, we identified correlations that could potentially forecast the risk of malignant transformation and summarized them in the form of\n                      <jats:styled-content style=\"fixed-case\">RICH<\/jats:styled-content>\n                      score.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.15932","type":"journal-article","created":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T09:34:21Z","timestamp":1567935261000},"page":"377-384","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective analysis of alpha\u2010human papillomavirus (\n                    <scp>HPV<\/scp>\n                    ) types in tissue samples from anogenital dysplasias \u2013 introduction of the\n                    <scp>RICH<\/scp>\n                    (Risk of\n                    <scp>HPV<\/scp>\n                    \u2010related Carcinoma in\n                    <scp>HIV<\/scp>\n                    <sup>+\/\u2212<\/sup>\n                    patients) score"],"prefix":"10.1111","volume":"34","author":[{"given":"J.A.","family":"Hildebrand","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Fischbeck","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hundsdoerfer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Clanner\u2010Engelshofen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marsela","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wollenberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Flaig","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"French","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reinholz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.05.010"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30143-7"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep05807"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2018.04.003"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/613150"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603695"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.02.002"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1375-0"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.006"},{"key":"e_1_2_6_12_1","first-page":"1934","article-title":"Human papillomavirus 16 and 18\u00a0L1 serology compared across anogenital cancer sites","volume":"61","author":"Carter JJ","year":"2001","journal-title":"Can Res"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.054"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5376"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/318071"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92636-0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70364-X"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6016"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081355"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010971"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.016"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1500"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09712.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70080-3"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09028-4"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27485"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1208087"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185332"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-018-2791-2"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0524-0_ch10"},{"key":"e_1_2_6_33_1","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000199019.50451.a8"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25671"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12726"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2009.02.003"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283434594"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.15932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.15932","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:16:54Z","timestamp":1791281814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.15932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/jdv.15932"],"URL":"https:\/\/doi.org\/10.1111\/jdv.15932","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"2019-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}